Bioqual Inc banner

Bioqual Inc
OTC:BIOQ

Watchlist Manager
Bioqual Inc Logo
Bioqual Inc
OTC:BIOQ
Watchlist
Price: 37.51 USD Market Closed
Market Cap: $33.4m

Bioqual Inc
Investor Relations

Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The firm also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. The In vitro services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays. The firm provides its services to the federal government, universities and the life science and pharmaceutical industries.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Mark G. Lewis Ph.D.
Chairman of the Board, CEO & President
No Bio Available
Mr. Charles C. Kirk Jr., CPA
Chief Financial Officer
No Bio Available
Mitch Franklin
Chief Operating Officer
No Bio Available
Ms. Hanne Andersen-Elyard Ph.D.
Chief Scientific Officer
No Bio Available

Contacts

Address
MARYLAND
Rockville
9600 Medical Center Drive, Suite 101
Contacts
+12404047654.0
www.bioqual.com